Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.
about
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection.Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.Graft versus tumor effect in the brain of a child with recurrent metastatic medulloblastoma.
P2860
Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Donor NK cell licensing in con ...... em cell transplant recipients.
@en
Donor NK cell licensing in con ...... em cell transplant recipients.
@nl
type
label
Donor NK cell licensing in con ...... em cell transplant recipients.
@en
Donor NK cell licensing in con ...... em cell transplant recipients.
@nl
prefLabel
Donor NK cell licensing in con ...... em cell transplant recipients.
@en
Donor NK cell licensing in con ...... em cell transplant recipients.
@nl
P2093
P2860
P50
P356
P1476
Donor NK cell licensing in con ...... tem cell transplant recipients
@en
P2093
Agnieszka Tomaszewska
Agnieszka Witkowska
And Andrzej Lange
Andrzej Hellmann
Andrzej Szczepiński
Anna Gronkowska
Anna Marosz-Rudnicka
Barbara Nasiłowska-Adamska
Barbara Wysoczańska
P2860
P304
P356
10.1002/AJH.23802
P50
P577
2014-08-27T00:00:00Z